Q1 2022 Oncternal Therapeutics Inc Earnings Call Transcript
Greetings and welcome to Oncternal Therapeutics, Inc. Third (sic) [First] Quarter 2022 Financial Results Call. (Operator Instructions) It is now my pleasure to introduce your host, Richard Vincent, Chief Financial Officer. Thank you. You may begin.
Thank you, Doug. Good afternoon, everyone and thank you for joining us today as we cover our First Quarter 2022 earnings. Joining me on the call this afternoon are our President and CEO, Dr. James Breitmeyer; and our CMO, Dr. Salim Yazji.
Today's call includes a business update and discussion of our 2022 first quarter financial results, which will be followed by Q&A. Today's press release and a replay of today's call will be available on the Investor Relations section of Oncternal website for at least the next 30 days. We filed our 10-Q for the first quarter 2022 earlier today as well. Please note that certain information discussed on today's call is covered under the safe harbor provisions of the Private Securities
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |